Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma (Q67126141)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma |
clinical trial |
Statements
Pilot Single Arm, Single Center, Open Label Trial of Pembrolizumab in Patients With Intermediate and High Risk Smoldering Multiple Myeloma (English)
0 references
20 July 2016
0 references
30 July 2020
0 references
13
0 references
18 year
0 references